Literature DB >> 8827692

Hydroperoxides of erythrocyte phospholipid molecular species formed by lipoxygenase correlate with alpha-tocopherol levels.

P Therond1, M Couturier, J F Demelier, F Lemonnier.   

Abstract

The hydroperoxides corresponding to the main molecular species of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) were determined after lipoxygenase treatment of erythrocyte membranes from healthy children. This work was a preliminary study prior to applying this analytical procedure to erythrocyte membranes from children with diseases associated with vitamin E deficiency. The total molecular species corresponding to 20:4 and 22:6 associated with 16:0 and 18:0 were significantly higher in PE (26.94 +/- 4.70 nmol/mg protein) than in PC (20.14 +/- 6.70 nmol/mg protein); these concentrations represented 63% of the total molecular species in PE and 22% in PC. However, the concentrations of hydroperoxides produced from these polyunsaturated fatty acid molecular species were in the same order of magnitude in PC (3.98 +/- 1.56 nmol/mg protein) and in PE (3.61 +/- 1.63 nmol/mg protein). In contrast, the molecular species concentrations containing two double bonds, such as 16:0/18:2 and 18:0/18:2 and their corresponding hydroperoxides, were clearly more elevated in PC than in PE. There was a positive relationship between the concentrations of alpha-tocopherol and each hydroperoxide of PC and PE, and this association was particularly strong in PE (P < or = 0.0001). These results suggest that alpha-tocopherol exerts a stabilizing effect toward hydroperoxides, limiting their further degradation into peroxyl radicals. The protective effect of alpha-tocopherol could be more effective in PE because more polyunsaturated fatty acids were present.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827692     DOI: 10.1007/bf02522885

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  22 in total

1.  Determination of alpha-tocopherol in tissues and plasma by high-performance liquid chromatography.

Authors:  B J Zaspel; A S Csallany
Journal:  Anal Biochem       Date:  1983-04-01       Impact factor: 3.365

2.  An improved procedure for the isolation of ghost membranes from human red blood cells.

Authors:  G W Burton; K U Ingold; K E Thompson
Journal:  Lipids       Date:  1981-12       Impact factor: 1.880

3.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

4.  Thiobarbituric acid-reactive substances from peroxidized lipids.

Authors:  H Kosugi; T Kojima; K Kikugawa
Journal:  Lipids       Date:  1989-10       Impact factor: 1.880

5.  The interaction between beta-carotene and lipoxygenase in plant and animal systems.

Authors:  L Lomnitski; R Bar-Natan; D Sklan; S Grossman
Journal:  Biochim Biophys Acta       Date:  1993-04-23

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  The relationship between alpha-tocopherol and phospholipid fatty acids in rat liver subcellular membrane fractions.

Authors:  J L Buttriss; A T Diplock
Journal:  Biochim Biophys Acta       Date:  1988-09-02

8.  Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography.

Authors:  Y Yamamoto; M H Brodsky; J C Baker; B N Ames
Journal:  Anal Biochem       Date:  1987-01       Impact factor: 3.365

9.  Rapid separation of neutral lipids, free fatty acids and polar lipids using prepacked silica Sep-Pak columns.

Authors:  J G Hamilton; K Comai
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

10.  Relationship between malondialdehyde production and arachidonate consumption during NADPH-supported microsomal lipid peroxidation.

Authors:  R A Jordan; J B Schenkman
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.